AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 138.32 |
| Open | 139.21 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 137.76 - 142.72 |
| 52-week range | 106.86 - 175.91 |
| Volume | |
| Avg. volume | 5,554,984 |
| Market cap | 251.053B |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | 20.08 |
| EPS (TTM) | 7.07 |
| Earnings date | 27 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | 5.64 (4.20%) |
| Ex-dividend date | 13 Oct 2022 |
| 1y target est | 158.61 |
- Zacks
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
- Zacks
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.
- PR Newswire
AbbVie to Host Third-Quarter 2022 Earnings Conference Call
AbbVie (NYSE: ABBV) will announce its third-quarter 2022 financial results on Friday, October 28, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.
© 2022 Yahoo. All rights reserved.
